Varian Medical Systems Company Profile (NYSE:VAR)

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems logoVarian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:VAR
  • CUSIP: 92220P10
  • Web:
  • Market Cap: $9.59 billion
  • Outstanding Shares: 91,921,000
Average Prices:
  • 50 Day Moving Avg: $103.32
  • 200 Day Moving Avg: $91.18
  • 52 Week Range: $75.20 - $107.08
  • Trailing P/E Ratio: 34.02
  • Foreward P/E Ratio: 23.40
  • P/E Growth: 2.72
Sales & Book Value:
  • Annual Revenue: $3.25 billion
  • Price / Sales: 2.95
  • Book Value: $14.04 per share
  • Price / Book: 7.43
  • EBIDTA: $625.1 million
  • Net Margins: 9.39%
  • Return on Equity: 24.82%
  • Return on Assets: 11.15%
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 1.52%
  • Quick Ratio: 1.20%
  • Average Volume: 922,384 shs.
  • Beta: 0.62
  • Short Ratio: 9.68

Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) announced its earnings results on Wednesday, April, 26th. The company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.01. The firm earned $655 million during the quarter, compared to analyst estimates of $639.26 million. Varian Medical Systems had a return on equity of 24.82% and a net margin of 9.39%. The business's revenue was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.09 EPS. View Varian Medical Systems' Earnings History.

When will Varian Medical Systems make its next earnings announcement?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share (EPS) guidance of $3.56-3.64 for the period, compared to the Thomson Reuters consensus estimate of $3.95. The company issued revenue guidance of +2-4%, compared to the consensus revenue estimate of $2.76 billion.Varian Medical Systems also updated its Q3 guidance to $0.92-0.96 EPS.

Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?

12 analysts have issued 1-year price objectives for Varian Medical Systems' stock. Their predictions range from $81.50 to $106.00. On average, they expect Varian Medical Systems' stock price to reach $92.14 in the next twelve months. View Analyst Ratings for Varian Medical Systems.

What are analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

  • 1. According to Zacks Investment Research, "Varian Medical's oncology and Proton therapy business growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. Varian has been winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe China and Africa present significant top-line growth opportunity in the near term. The company is opening up new offices in Africa and the Middle East, which shows that it is aware of the growth opportunities in the region. Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. Share price movement in the past three months has been encouraging, trading above the broader industry." (7/13/2017)
  • 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)

Who are some of Varian Medical Systems' key competitors?

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

  • R. Andrew Eckert, Independent Chairman of the Board
  • Dow R. Wilson, President, Chief Executive Officer
  • Timothy E. Guertin, Vice Chairman of the Board
  • Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
  • Gary E. Bischoping Jr., Chief Financial Officer
  • Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
  • John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
  • Rafael Torres, Senior Vice President - Business Development and Strategy
  • Jose Baselga M.D., Ph.D., Director
  • Jean-Luc Butel, Director

Who owns Varian Medical Systems stock?

Varian Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Alecta Pensionsforsakring Omsesidigt (3.09%), Oakbrook Investments LLC (0.35%), BB&T Corp (0.22%), BTIM Corp. (0.21%), DnB Asset Management AS (0.20%) and Marathon Asset Management LLP (0.19%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?

Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including Marathon Asset Management LLP, Cape Cod Five Cents Savings Bank, Smithbridge Asset Management Inc. DE, DnB Asset Management AS, BB&T Corp, Exxonmobil Investment Management Inc. TX, Oregon Public Employees Retirement Fund and US Bancorp DE. Company insiders that have sold Varian Medical Systems stock in the last year include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?

Varian Medical Systems' stock was acquired by a variety of institutional investors in the last quarter, including Oakbrook Investments LLC, Mn Services Vermogensbeheer B.V., Bedrijfstakpensioenfonds Voor DE Media PNO, Bank of Montreal Can, Aperio Group LLC, BTIM Corp., Fox Run Management L.L.C. and NN Investment Partners Holdings N.V.. View Insider Buying and Selling for Varian Medical Systems.

How do I buy Varian Medical Systems stock?

Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of Varian Medical Systems stock can currently be purchased for approximately $104.35.

MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  293 (Vote Outperform)
Underperform Votes:  264 (Vote Underperform)
Total Votes:  557
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Varian Medical Systems (NYSE:VAR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 5 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $92.14 (11.70% downside)

Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Robert W. BairdReiterated RatingNeutral$89.00 -> $99.00LowView Rating Details
5/17/2017AegisReiterated RatingHold$91.00LowView Rating Details
5/16/2017Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral -> Neutral$92.00LowView Rating Details
5/15/2017Citigroup Inc.UpgradeNeutral -> BuyLowView Rating Details
5/11/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
5/8/2017BTIG ResearchUpgradeNeutral -> Buy$106.00HighView Rating Details
4/27/2017Barrington ResearchDowngradeOutperform -> Market PerformHighView Rating Details
4/27/2017Royal Bank Of CanadaBoost Price TargetSector Perform -> Sector Perform$82.00 -> $90.00HighView Rating Details
4/24/2017Off Wall StreetInitiated CoverageSellLowView Rating Details
1/26/2017Evercore ISIDowngradeHold -> Sell$81.50N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetUnderweight$80.00 -> $86.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$87.00 -> $90.00N/AView Rating Details
10/20/2015J P Morgan Chase & CoReiterated RatingNeutral$95.00 -> $75.00N/AView Rating Details
(Data available from 7/20/2015 forward)


Earnings History for Varian Medical Systems (NYSE:VAR)
Earnings by Quarter for Varian Medical Systems (NYSE:VAR)
Earnings History by Quarter for Varian Medical Systems (NYSE VAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017$0.94N/AView Earnings Details
4/26/2017Q2 2017$0.88$0.89$639.26 million$655.00 millionViewN/AView Earnings Details
10/26/2016Q4112$1.34$1.38$880.29 million$912.00 millionViewListenView Earnings Details
7/27/2016Q316$1.17$1.22$779.90 million$789.40 millionViewListenView Earnings Details
4/27/2016Q216$1.08$1.09$769.56 million$758.80 millionViewListenView Earnings Details
1/27/2016Q116$0.94$0.99$748.01 million$757.00 millionViewListenView Earnings Details
10/28/2015Q4$1.10$1.04$813.18 million$817.80 millionViewListenView Earnings Details
7/29/2015Q3$1.10$1.13$810.41 million$784.00 millionViewListenView Earnings Details
4/29/2015Q215$1.00$1.05$799.66 million$759.40 millionViewN/AView Earnings Details
1/28/2015Q115$0.87$0.99$720.83 million$737.90 millionViewN/AView Earnings Details
10/22/2014Q415$1.21$1.02$837.86 million$812.10 millionViewListenView Earnings Details
7/23/2014Q314$1.09$1.08$767.52 million$747.70 millionViewN/AView Earnings Details
4/23/2014Q4112$1.03$1.04$772.84 million$779.00 millionViewN/AView Earnings Details
1/22/2014Q3112$0.90$0.91$718.23 million$712.00 millionViewN/AView Earnings Details
10/23/2013Q3112$1.12$1.08$779.02 million$770.00 millionViewN/AView Earnings Details
7/24/2013Q3 2013$1.01$1.03$749.01 million$726.20 millionViewN/AView Earnings Details
4/24/2013Q2 2013$1.02$1.04$758.02 million$768.40 millionViewN/AView Earnings Details
1/23/2013Q1 2013$0.87$0.86$676.15 million$678.40 millionViewN/AView Earnings Details
10/25/2012$1.03$1.08ViewN/AView Earnings Details
7/25/2012$0.94$0.96ViewN/AView Earnings Details
4/25/2012$0.96$0.96ViewN/AView Earnings Details
1/25/2012$0.75$0.79ViewN/AView Earnings Details
10/27/2011$0.97$0.95ViewN/AView Earnings Details
7/27/2011$0.83$0.83ViewN/AView Earnings Details
4/27/2011$0.85$0.86ViewN/AView Earnings Details
1/26/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Varian Medical Systems (NYSE:VAR)
2017 EPS Consensus Estimate: $4.15
2018 EPS Consensus Estimate: $4.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$1.04$1.06$1.05
Q2 20172$0.91$1.08$1.00
Q3 20172$0.94$0.95$0.95
Q4 20172$1.12$1.19$1.16
Q1 20182$0.92$1.03$0.98
Q2 20182$1.03$1.07$1.05
Q3 20182$1.07$1.17$1.12
Q4 20182$1.27$1.39$1.33
(Data provided by Zacks Investment Research)


Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)
Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.55%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2017John W KuoSVPSell1,597$104.43$166,774.71View SEC Filing  
7/13/2017Kolleen T KennedyEVPSell2,021$104.73$211,659.33View SEC Filing  
7/12/2017John W KuoSVPSell863$104.48$90,166.24View SEC Filing  
7/12/2017Kolleen T KennedyEVPSell1,088$104.49$113,685.12View SEC Filing  
7/10/2017Dow R WilsonInsiderSell15,060$103.37$1,556,752.20View SEC Filing  
6/20/2017Kolleen T KennedyEVPSell26,092$105.00$2,739,660.00View SEC Filing  
6/13/2017John W KuoSVPSell734$101.91$74,801.94View SEC Filing  
6/12/2017John W KuoSVPSell863$101.25$87,378.75View SEC Filing  
6/12/2017Kolleen T KennedyEVPSell1,087$101.20$110,004.40View SEC Filing  
6/9/2017Timothy E GuertinDirectorSell16,000$103.22$1,651,520.00View SEC Filing  
6/8/2017Mark R LaretDirectorSell1,428$103.47$147,755.16View SEC Filing  
6/1/2017Kolleen T KennedyEVPSell56,573$99.76$5,643,722.48View SEC Filing  
5/31/2017John W KuoSVPSell19,819$99.67$1,975,359.73View SEC Filing  
5/12/2017John W KuoSVPSell862$96.39$83,088.18View SEC Filing  
5/2/2017Susan L BostromDirectorSell3,589$91.08$326,886.12View SEC Filing  
4/12/2017John W KuoSVPSell864$89.74$77,535.36View SEC Filing  
3/17/2017John W KuoSVPSell3,876$91.75$355,623.00View SEC Filing  
3/13/2017John W KuoSVPSell862$87.89$75,761.18View SEC Filing  
3/1/2017John W KuoSVPSell10,353$84.81$878,037.93View SEC Filing  
1/5/2017Dow R WilsonInsiderSell13,334$88.74$1,183,259.16View SEC Filing  
12/8/2016John W KuoSVPSell1,267$90.33$114,448.11View SEC Filing  
12/5/2016Dow R WilsonInsiderSell10,000$90.03$900,300.00View SEC Filing  
11/7/2016Dow R WilsonInsiderSell10,000$90.59$905,900.00View SEC Filing  
10/31/2016Timothy E GuertinDirectorSell4,000$90.32$361,280.00View SEC Filing  
10/20/2016John W KuoSVPSell21,266$103.70$2,205,284.20View SEC Filing  
10/5/2016Dow R WilsonInsiderSell10,000$99.44$994,400.00View SEC Filing  
10/3/2016Elisha W FinneyCFOSell4,668$98.87$461,525.16View SEC Filing  
9/15/2016John W KuoSVPSell4,073$95.47$388,849.31View SEC Filing  
9/7/2016Elisha W FinneyCFOSell9,000$96.95$872,550.00View SEC Filing  
9/6/2016Dow R WilsonInsiderSell10,000$96.08$960,800.00View SEC Filing  
9/1/2016Elisha W FinneyCFOSell2,000$95.82$191,640.00View SEC Filing  
8/5/2016Dow R WilsonInsiderSell10,000$95.14$951,400.00View SEC Filing  
8/1/2016Clarence R VerhoefSVPSell9,483$94.88$899,747.04View SEC Filing  
8/1/2016Elisha W FinneyCFOSell25,334$94.90$2,404,196.60View SEC Filing  
8/1/2016Timothy E. GuertinDirectorSell4,000$94.88$379,520.00View SEC Filing  
7/5/2016Dow R WilsonCEOSell10,000$82.08$820,800.00View SEC Filing  
6/27/2016Dow R WilsonCEOSell10,000$78.27$782,700.00View SEC Filing  
6/8/2016Ruediger Naumann-EtienneDirectorSell1,000$84.83$84,830.00View SEC Filing  
6/3/2016Mark R LaretDirectorSell1,545$83.48$128,976.60View SEC Filing  
5/2/2016Timothy E. GuertinDirectorSell4,000$81.55$326,200.00View SEC Filing  
4/20/2016Elisha W FinneyCFOSell4,000$85.95$343,800.00View SEC Filing  
4/18/2016Clarence R VerhoefSVPSell2,500$85.00$212,500.00View SEC Filing  
3/23/2016Dow R WilsonCEOSell45,650$78.86$3,599,959.00View SEC Filing  
3/10/2016Ruediger Naumann-EtienneDirectorSell428$77.99$33,379.72View SEC Filing  
3/7/2016Timothy E. GuertinDirectorSell4,000$79.47$317,880.00View SEC Filing  
2/17/2016Elisha W. FinneyCFOSell2,454$78.59$192,859.86View SEC Filing  
12/7/2015Dow R. WilsonCEOSell9,000$80.00$720,000.00View SEC Filing  
12/2/2015R Andrew EckertDirectorSell3,000$81.67$245,010.00View SEC Filing  
11/24/2015Elisha W. FinneyCFOSell2,334$80.90$188,820.60View SEC Filing  
11/6/2015Dow R. WilsonCEOSell18,000$80.26$1,444,680.00View SEC Filing  
9/8/2015Dow R. WilsonCEOSell9,000$80.05$720,450.00View SEC Filing  
7/6/2015Dow R WilsonCEOSell9,000$85.80$772,200.00View SEC Filing  
7/2/2015Elisha W FinneyCFOSell2,000$85.95$171,900.00View SEC Filing  
7/1/2015Timothy E GuertinDirectorSell25,000$84.20$2,105,000.00View SEC Filing  
6/5/2015Dow R WilsonCEOSell9,000$86.29$776,610.00View SEC Filing  
6/1/2015Elisha W FinneyCFOSell2,000$85.99$171,980.00View SEC Filing  
6/1/2015Timothy E GuertinDirectorSell25,000$86.08$2,152,000.00View SEC Filing  
5/6/2015Dow R WilsonCEOSell9,000$86.64$779,760.00View SEC Filing  
4/17/2015Dow R WilsonCEOSell18,760$93.63$1,756,498.80View SEC Filing  
4/1/2015Elisha W FinneyCFOSell5,000$92.76$463,800.00View SEC Filing  
4/1/2015Timothy E GuertinDirectorSell25,000$92.76$2,319,000.00View SEC Filing  
3/20/2015Dow R WilsonCEOSell18,759$94.44$1,771,599.96View SEC Filing  
3/16/2015Kolleen T KennedyEVPSell1,972$95.00$187,340.00View SEC Filing  
3/6/2015Timothy E GuertinDirectorSell4,000$93.50$374,000.00View SEC Filing  
3/2/2015Elisha W FinneyCFOSell5,000$93.44$467,200.00View SEC Filing  
3/2/2015Timothy E GuertinDirectorSell50,000$93.48$4,674,000.00View SEC Filing  
2/23/2015Elisha W FinneyCFOSell1,326$92.97$123,278.22View SEC Filing  
2/10/2015Mark R LaretDirectorSell10,000$92.32$923,200.00View SEC Filing  
2/3/2015Venkatraman ThyagarajanDirectorSell10,000$92.71$927,100.00View SEC Filing  
2/2/2015Dow R WilsonCEOSell60,000$91.78$5,506,800.00View SEC Filing  
2/2/2015Elisha W FinneyCFOSell6,667$91.79$611,963.93View SEC Filing  
2/2/2015John W KuoSVPSell3,490$92.04$321,219.60View SEC Filing  
2/2/2015Ruediger Naumann-EtienneDirectorSell10,000$91.87$918,700.00View SEC Filing  
1/5/2015Timothy E GuertinDirectorSell50,000$86.27$4,313,500.00View SEC Filing  
1/2/2015Elisha W FinneyCFOSell15,000$87.05$1,305,750.00View SEC Filing  
12/11/2014Timothy E GuertinDirectorSell105,000$86.67$9,100,350.00View SEC Filing  
12/1/2014Elisha W FinneyCFOSell21,000$88.72$1,863,120.00View SEC Filing  
11/24/2014Elisha W FinneyCFOSell2,930$88.24$258,543.20View SEC Filing  
11/17/2014Elisha W FinneyCFOSell1,837$87.71$161,123.27View SEC Filing  
11/11/2014Kolleen T KennedySVPSell1,242$85.79$106,551.18View SEC Filing  
11/10/2014Ruediger Naumann-EtienneDirectorSell5,000$85.31$426,550.00View SEC Filing  
11/3/2014Elisha W FinneyCFOSell25,000$83.82$2,095,500.00View SEC Filing  
11/3/2014Timothy E GuertinDirectorSell80,000$83.72$6,697,600.00View SEC Filing  
10/29/2014Elisha W FinneyCFOSell10,000$83.95$839,500.00View SEC Filing  
10/27/2014Kolleen T KennedySVPSell1,240$81.00$100,440.00View SEC Filing  
10/1/2014Elisha W FinneyCFOSell15,000$79.98$1,199,700.00View SEC Filing  
9/11/2014John W KuoSVPSell605$85.82$51,921.10View SEC Filing  
9/2/2014Elisha W FinneyCFOSell20,000$85.18$1,703,600.00View SEC Filing  
8/20/2014Venkatraman ThyagarajanDirectorSell5,000$84.25$421,250.00View SEC Filing  
8/7/2014Elisha W FinneyCFOSell5,000$83.95$419,750.00View SEC Filing  
8/1/2014Elisha W FinneyCFOSell15,000$81.66$1,224,900.00View SEC Filing  
8/1/2014Timothy E GuertinDirectorSell80,000$81.69$6,535,200.00View SEC Filing  
7/9/2014John W KuoSVPSell582$85.00$49,470.00View SEC Filing  
7/1/2014Elisha W FinneyCFOSell20,000$83.86$1,677,200.00View SEC Filing  
6/23/2014John W KuoSVPSell1,745$85.00$148,325.00View SEC Filing  
6/16/2014Kolleen T KennedySVPSell1,416$82.42$116,706.72View SEC Filing  
6/2/2014Elisha W FinneyCFOSell10,000$82.35$823,500.00View SEC Filing  
5/12/2014Kolleen KennedySVPSell1,417$81.96$116,137.32View SEC Filing  
5/1/2014Elisha FinneyCFOSell10,000$78.99$789,900.00View SEC Filing  
5/1/2014Timothy GuertinDirectorSell80,000$78.98$6,318,400.00View SEC Filing  
4/11/2014Kolleen T KennedySVPSell640$72.15$46,176.00View SEC Filing  
4/1/2014Elisha FinneyCFOSell10,000$83.97$839,700.00View SEC Filing  
3/17/2014Clarence VerhoefSVPSell1,140$84.70$96,558.00View SEC Filing  
3/11/2014Kolleen KennedySVPSell1,417$84.39$119,580.63View SEC Filing  
3/10/2014Timothy GuertinDirectorSell80,000$84.05$6,724,000.00View SEC Filing  
3/3/2014Elisha FinneyCFOSell10,000$83.41$834,100.00View SEC Filing  
2/21/2014Mark LaretDirectorSell1,411$84.06$118,608.66View SEC Filing  
2/11/2014Kolleen KennedySVPSell1,416$80.59$114,115.44View SEC Filing  
2/10/2014R Andrew EckertDirectorSell5,887$80.52$474,021.24View SEC Filing  
2/3/2014Elisha FinneyCFOSell10,000$79.34$793,400.00View SEC Filing  
2/3/2014Timothy GuertinDirectorSell27,000$79.34$2,142,180.00View SEC Filing  
1/31/2014Susan BostromDirectorSell18,900$81.50$1,540,350.00View SEC Filing  
1/2/2014Elisha FinneyCFOSell24,321$77.69$1,889,498.49View SEC Filing  
1/2/2014Richard LevyDirectorSell20,000$77.68$1,553,600.00View SEC Filing  
12/30/2013John KuoSVPSell3,027$77.08$233,321.16View SEC Filing  
12/23/2013Clarence VerhoefSVPSell1,297$76.13$98,740.61View SEC Filing  
12/9/2013Dow WilsonCEOSell95,000$79.09$7,513,550.00View SEC Filing  
12/4/2013Robert KlugeSVPSell12,932$80.00$1,034,560.00View SEC Filing  
12/2/2013Elisha FinneyCFOSell10,000$79.04$790,400.00View SEC Filing  
12/2/2013Richard LevyDirectorSell20,000$79.04$1,580,800.00View SEC Filing  
12/2/2013Robert KlugeSVPSell9,889$79.00$781,231.00View SEC Filing  
11/29/2013Kolleen KennedySVPSell9,307$78.00$725,946.00View SEC Filing  
11/25/2013Kolleen KennedySVPSell2,972$75.49$224,356.28View SEC Filing  
11/22/2013Elisha FinneyCFOSell1,617$74.83$121,000.11View SEC Filing  
11/14/2013Elisha FinneyCFOSell5,000$74.95$374,750.00View SEC Filing  
11/1/2013Elisha W FinneyCFOSell5,000$72.27$361,350.00View SEC Filing  
11/1/2013Richard M LevyDirectorSell20,000$72.27$1,445,400.00View SEC Filing  
10/14/2013Robert KlugeSVPSell13,889$78.00$1,083,342.00View SEC Filing  
10/10/2013Robert KlugeSVPSell13,871$77.00$1,068,067.00View SEC Filing  
9/20/2013Kolleen KennedySVPSell1,247$76.00$94,772.00View SEC Filing  
9/16/2013Elisha FinneyCFOSell16,334$74.95$1,224,233.30View SEC Filing  
9/16/2013Kolleen KennedySVPSell2,562$75.00$192,150.00View SEC Filing  
9/11/2013Elisha W FinneyCFOSell23,666$74.95$1,773,766.70View SEC Filing  
9/3/2013Elisha FinneyCFOSell5,000$70.95$354,750.00View SEC Filing  
9/3/2013Richard LevyDirectorSell20,000$70.95$1,419,000.00View SEC Filing  
8/8/2013Kolleen KennedySVPSell2,400$73.50$176,400.00View SEC Filing  
8/1/2013Elisha W FinneyCFOSell5,000$72.81$364,050.00View SEC Filing  
8/1/2013R Andrew EckertDirectorSell1,375$72.93$100,278.75View SEC Filing  
7/19/2013John W KuoSVPSell1,817$72.00$130,824.00View SEC Filing  
7/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
7/16/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
6/10/2013Timothy E GuertinDirectorSell27,000$68.81$1,857,870.00View SEC Filing  
5/21/2013Elisha W FinneyCFOSell2,313$69.86$161,586.18View SEC Filing  
5/14/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
5/14/2013John W KuoSVPSell1,112$70.00$77,840.00View SEC Filing  
5/14/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
2/14/2013John W KuoSVPSell1,111$71.05$78,936.55View SEC Filing  
9/4/2012Kolleen T KennedySVPSell1,900$64.00$121,600.00View SEC Filing  
8/20/2012Elisha W FinneyCFOSell4,000$59.95$239,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Varian Medical Systems (NYSE:VAR)
Latest Headlines for Varian Medical Systems (NYSE:VAR)
DateHeadline logo Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.94 Per Share - July 19 at 11:34 AM logoVarian Medical Systems, Inc. (VAR) Set to Announce Earnings on Wednesday - July 19 at 9:15 AM logoVarian Medical Systems, Inc. (VAR) Receives Consensus Recommendation of "Hold" from Brokerages - July 18 at 10:35 PM logoVarian Eclipse Users Generate Highest Scoring Plans in International Treatment Plan Competition - July 18 at 9:37 AM logoVarian Medical Systems, Inc. (NYSE:VAR) Given "Neutral" Rating at Robert W. Baird - July 15 at 8:28 PM logoVarian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo Sells 863 Shares - July 14 at 8:46 PM logoInsider Selling: Varian Medical Systems, Inc. (NYSE:VAR) EVP Sells 1,088 Shares of Stock - July 14 at 8:46 PM logoForm 4 VARIAN MEDICAL SYSTEMS For: Jul 12 Filed by: KUO JOHN W - July 14 at 9:40 AM logoInsider Selling: Varian Medical Systems, Inc. (NYSE:VAR) SVP Sells 1,597 Shares of Stock - July 13 at 10:53 PM logoKolleen T. Kennedy Sells 2,021 Shares of Varian Medical Systems, Inc. (VAR) Stock - July 13 at 10:53 PM logoVarian Medical Systems, Inc. (NYSE:VAR) Upgraded to "Strong-Buy" at BidaskClub - July 13 at 10:20 PM logoZacks Investment Research Lowers Varian Medical Systems, Inc. (VAR) to Hold - July 13 at 8:51 AM logoVarian Medical Systems, Inc. (VAR) Insider Sells $1,556,752.20 in Stock - July 11 at 10:52 PM logoLeading Cancer Center Commences Advanced Treatments Using Varian Edge™ Radiosurgery System - July 11 at 9:07 AM logoPhibro Animal Health & Zydus Cadila Plan to Expand in India - Nasdaq - July 8 at 4:01 PM logoHere's Why You Should Add Abbott Laboratories Right Now - Nasdaq - July 6 at 4:05 PM logoHere's Why You Should Add Abbott Laboratories Right Now - July 6 at 4:05 PM logoAnalysts’ Recommendations for Varian Medical Systems - July 4 at 8:29 AM logoVarian Medical Systems: Analyzing Its Stock Performance - July 4 at 8:29 AM logoVarian Medical Systems Gets New Product Approval - July 3 at 8:06 AM logoConcord Medical To Install Proton Therapy System at Guangzhou Concord Cancer Hospital - PR Newswire (press release) - July 1 at 8:44 AM logoVarian Medical Systems Receives FDA 510(k) Clearance for Halcyon Treatment System - June 29 at 4:08 PM logoVarian Medical Systems, Inc. (VAR) Downgraded by BidaskClub to Buy - June 29 at 3:08 PM logoVarian Medical Systems, Inc. (VAR) Raised to "Buy" at Zacks Investment Research - June 27 at 1:36 PM logoVarian Medical Systems Schedules Third Quarter FY2017 News Release and Conference Call - June 26 at 3:24 PM logo$663.22 Million in Sales Expected for Varian Medical Systems, Inc. (VAR) This Quarter - June 25 at 1:02 PM logoVarian Medical Systems, Inc. (VAR) Given Consensus Recommendation of "Hold" by Analysts - June 23 at 8:46 PM logoZacks: Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.94 Per Share - June 23 at 11:27 AM logoVarian Medical Systems, Inc. (VAR) Raised to Strong-Buy at BidaskClub - June 22 at 3:32 PM logoVarian Works with Sify Technologies to Host Data Remotely Across CTSI Network of Cancer Centers in India - June 22 at 2:30 PM logoMajor Milestone for UK's First High Energy Proton Therapy Center with Varian Cyclotron Installation - June 22 at 2:30 PM logoInsider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 26,092 Shares of Stock - June 21 at 7:24 PM logoETFs with exposure to Varian Medical Systems, Inc. : June 19, 2017 - June 20 at 9:02 AM logoVarian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation - June 20 at 9:02 AM logoVarian Showcases Halcyon System at DEGRO Meet, Stock Up - Nasdaq - June 17 at 7:02 AM logoVarian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q2, 2017 By the Numbers : June 16, 2017 - June 17 at 7:02 AM logoVarian Spotlights New Halcyon Radiotherapy Treatment System at DEGRO 2017 - June 15 at 3:44 PM logoJohn W. Kuo Sells 734 Shares of Varian Medical Systems, Inc. (VAR) Stock - June 14 at 10:48 PM logoBidaskClub Downgrades Varian Medical Systems, Inc. (VAR) to Buy - June 14 at 3:32 PM logoInsider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 1,087 Shares of Stock - June 13 at 10:32 PM logoVarian Medical Systems, Inc. (VAR) SVP Sells $87,378.75 in Stock - June 13 at 10:32 PM logoVarian Medical Systems, Inc. (VAR) Director Sells $1,651,520.00 in Stock - June 12 at 10:32 PM logoFinancial Survey: Rewalk Robotics (RWLK) vs. Varian Medical Systems (VAR) - June 10 at 12:04 PM logoMark R. Laret Sells 1,428 Shares of Varian Medical Systems, Inc. (VAR) Stock - June 9 at 8:20 PM logoVarian Joins Partnership to Develop Radiotherapy Centers in Vietnam - June 5 at 11:22 AM logoInsider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 56,573 Shares of Stock - June 2 at 7:43 PM logoInsider Selling: Varian Medical Systems, Inc. (VAR) SVP Sells 19,819 Shares of Stock - June 1 at 4:28 PM logo Brokerages Expect Varian Medical Systems, Inc. (VAR) Will Post Quarterly Sales of $663.22 Million - May 31 at 11:08 AM logoVarian Medical at a 52-Week High: What's Driving the Stock? - Nasdaq - Nasdaq - May 30 at 8:27 PM logoVarian Medical (VAR) Up 9.8% Since Earnings Report: Can It Continue? - Nasdaq - May 30 at 8:27 PM



Varian Medical Systems (VAR) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by Staff